Cargando…

Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study

BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Katherine E., Nyiro, Joyce, Agoti, Charles N., Maitha, Eric, Nyagwange, James, Karani, Angela, Bottomley, Christian, Murunga, Nickson, Githinji, George, Mutunga, Martin, Ochola‐Oyier, Lynette Isabella, Kombe, Ivy, Nyaguara, Amek, Kagucia, E. Wangeci, Warimwe, George, Agweyu, Ambrose, Tsofa, Benjamin, Bejon, Philip, Scott, J. Anthony G., Nokes, David James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522480/
https://www.ncbi.nlm.nih.gov/pubmed/37752066
http://dx.doi.org/10.1111/irv.13185
_version_ 1785110363998519296
author Gallagher, Katherine E.
Nyiro, Joyce
Agoti, Charles N.
Maitha, Eric
Nyagwange, James
Karani, Angela
Bottomley, Christian
Murunga, Nickson
Githinji, George
Mutunga, Martin
Ochola‐Oyier, Lynette Isabella
Kombe, Ivy
Nyaguara, Amek
Kagucia, E. Wangeci
Warimwe, George
Agweyu, Ambrose
Tsofa, Benjamin
Bejon, Philip
Scott, J. Anthony G.
Nokes, David James
author_facet Gallagher, Katherine E.
Nyiro, Joyce
Agoti, Charles N.
Maitha, Eric
Nyagwange, James
Karani, Angela
Bottomley, Christian
Murunga, Nickson
Githinji, George
Mutunga, Martin
Ochola‐Oyier, Lynette Isabella
Kombe, Ivy
Nyaguara, Amek
Kagucia, E. Wangeci
Warimwe, George
Agweyu, Ambrose
Tsofa, Benjamin
Bejon, Philip
Scott, J. Anthony G.
Nokes, David James
author_sort Gallagher, Katherine E.
collection PubMed
description BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso‐oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR‐positive in the household; naso‐oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1–2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission. RESULTS: A total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow‐up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7‐day secondary attack rate was 4% (95% CI 1%–10%), the 14‐day secondary attack rate was 28% (95% CI 17%–40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%–34%). Antibody to SARS‐CoV‐2 spike protein at enrolment was not associated with risk of becoming a secondary case. CONCLUSION: Households in our setting experienced a lower 7‐day attack rate than a recent meta‐analysis indicated as the global average (23%–43% depending on variant), and infection is mostly asymptomatic in our setting.
format Online
Article
Text
id pubmed-10522480
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105224802023-09-28 Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study Gallagher, Katherine E. Nyiro, Joyce Agoti, Charles N. Maitha, Eric Nyagwange, James Karani, Angela Bottomley, Christian Murunga, Nickson Githinji, George Mutunga, Martin Ochola‐Oyier, Lynette Isabella Kombe, Ivy Nyaguara, Amek Kagucia, E. Wangeci Warimwe, George Agweyu, Ambrose Tsofa, Benjamin Bejon, Philip Scott, J. Anthony G. Nokes, David James Influenza Other Respir Viruses Original Articles BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso‐oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR‐positive in the household; naso‐oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1–2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission. RESULTS: A total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow‐up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7‐day secondary attack rate was 4% (95% CI 1%–10%), the 14‐day secondary attack rate was 28% (95% CI 17%–40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%–34%). Antibody to SARS‐CoV‐2 spike protein at enrolment was not associated with risk of becoming a secondary case. CONCLUSION: Households in our setting experienced a lower 7‐day attack rate than a recent meta‐analysis indicated as the global average (23%–43% depending on variant), and infection is mostly asymptomatic in our setting. John Wiley and Sons Inc. 2023-09-26 /pmc/articles/PMC10522480/ /pubmed/37752066 http://dx.doi.org/10.1111/irv.13185 Text en © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Gallagher, Katherine E.
Nyiro, Joyce
Agoti, Charles N.
Maitha, Eric
Nyagwange, James
Karani, Angela
Bottomley, Christian
Murunga, Nickson
Githinji, George
Mutunga, Martin
Ochola‐Oyier, Lynette Isabella
Kombe, Ivy
Nyaguara, Amek
Kagucia, E. Wangeci
Warimwe, George
Agweyu, Ambrose
Tsofa, Benjamin
Bejon, Philip
Scott, J. Anthony G.
Nokes, David James
Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
title Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
title_full Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
title_fullStr Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
title_full_unstemmed Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
title_short Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
title_sort symptom prevalence and secondary attack rate of sars‐cov‐2 in rural kenyan households: a prospective cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522480/
https://www.ncbi.nlm.nih.gov/pubmed/37752066
http://dx.doi.org/10.1111/irv.13185
work_keys_str_mv AT gallagherkatherinee symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT nyirojoyce symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT agoticharlesn symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT maithaeric symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT nyagwangejames symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT karaniangela symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT bottomleychristian symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT murunganickson symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT githinjigeorge symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT mutungamartin symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT ocholaoyierlynetteisabella symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT kombeivy symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT nyaguaraamek symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT kaguciaewangeci symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT warimwegeorge symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT agweyuambrose symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT tsofabenjamin symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT bejonphilip symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT scottjanthonyg symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy
AT nokesdavidjames symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy